• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促肾上腺皮质激素释放因子(CRF)受体亚型对肽类配体N端截短的差异反应性。

Differential responsiveness of CRF receptor subtypes to N-terminal truncation of peptidic ligands.

作者信息

Brauns Olaf, Brauns Simone, Zimmermann Bodo, Jahn Olaf, Spiess Joachim

机构信息

Department of Molecular Neuroendocrinology, Max Planck Institute for Experimental Medicine, Hermann Rein Street 3, Goettingen, Germany.

出版信息

Peptides. 2002 May;23(5):881-8. doi: 10.1016/s0196-9781(02)00014-1.

DOI:10.1016/s0196-9781(02)00014-1
PMID:12084518
Abstract

The role of the N-terminal domains of corticotropin-releasing factor (CRF) and CRF-like peptides in receptor subtype selectivity, ligand affinity and biological potency was investigated. Therefore, human CRF(12-41), human URP(12-38) and antisauvagine-30 (aSvg) were N-terminally prolonged by consecutive addition of one or two amino acids. The peptides obtained were tested for their binding affinities to rat CRF1 and murine CRF(2beta) receptor, and their capability to stimulate cAMP-release by HEK cells producing either receptor. It was observed that human CRF N-terminally truncated by eight residues was bound with high affinity to CRF2 receptor (Ki=5.4nM), whereas affinity for CRF1 receptor was decreased (Ki=250 nM). A similar shift of affinity was found with sauvagine (Svg) analogs. Truncation of human URP analogs did not affect their preference for CRF(2beta) receptor, but reduced their affinity. Changes in affinity were positively correlated with changes in potency. These results indicated that CRF1 receptor was more stringent in its structural requirements for ligands to exhibit high affinity binding than CRF(2beta) receptor.

摘要

研究了促肾上腺皮质激素释放因子(CRF)和CRF样肽的N端结构域在受体亚型选择性、配体亲和力和生物学活性方面的作用。因此,通过连续添加一个或两个氨基酸对人CRF(12-41)、人URP(12-38)和抗 sauvagine-30(aSvg)进行N端延长。对所得肽进行了与大鼠CRF1和小鼠CRF(2β)受体的结合亲和力测试,以及它们刺激产生任一受体的HEK细胞释放cAMP的能力测试。观察到N端截短8个残基的人CRF与CRF2受体具有高亲和力结合(Ki = 5.4 nM),而对CRF1受体的亲和力降低(Ki = 250 nM)。在sauvagine(Svg)类似物中也发现了类似的亲和力变化。人URP类似物的截短不影响它们对CRF(2β)受体的偏好,但降低了它们的亲和力。亲和力的变化与活性的变化呈正相关。这些结果表明,CRF1受体对配体表现出高亲和力结合的结构要求比CRF(2β)受体更严格。

相似文献

1
Differential responsiveness of CRF receptor subtypes to N-terminal truncation of peptidic ligands.促肾上腺皮质激素释放因子(CRF)受体亚型对肽类配体N端截短的差异反应性。
Peptides. 2002 May;23(5):881-8. doi: 10.1016/s0196-9781(02)00014-1.
2
Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.促肾上腺皮质激素释放因子受体(CRFR)肽拮抗剂的结构要求:CRFR2β选择性抗 sauvagine-30 的研发
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15264-9. doi: 10.1073/pnas.95.26.15264.
3
Development of a selective photoactivatable antagonist for corticotropin-releasing factor receptor, type 2 (CRF2).
Eur J Biochem. 2002 Nov;269(21):5288-94. doi: 10.1046/j.1432-1033.2002.03246.x.
4
125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.125I-酪氨酰蛙皮素:一种用于人促肾上腺皮质激素释放因子2α受体药理和生化研究的新型高亲和力放射性配体。
Mol Pharmacol. 1996 Sep;50(3):679-86.
5
Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.促肾上腺皮质激素释放因子(CRF)2型受体的肽配体结合特性:内源性表达受体的药理学、G蛋白偶联敏感性及CRF2受体选择性的决定因素
Peptides. 2005 Mar;26(3):457-70. doi: 10.1016/j.peptides.2004.10.019.
6
Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.尿皮质素II和III的三氨基酸基序决定了它们对促肾上腺皮质激素释放因子受体亚型的选择性。
Neuropharmacology. 2004 Aug;47(2):233-42. doi: 10.1016/j.neuropharm.2004.03.018.
7
Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.促肾上腺皮质激素释放因子(CRF)家族肽通过CRF受体对大鼠胰腺β细胞中Ca2+内流的调节作用。
Peptides. 2006 Jul;27(7):1814-9. doi: 10.1016/j.peptides.2006.01.011. Epub 2006 Feb 28.
8
Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.绵羊1型促肾上腺皮质激素释放因子受体(CRF1)及其羧基末端变体的结构与功能
Mol Cell Endocrinol. 1998 Sep 25;144(1-2):21-35. doi: 10.1016/s0303-7207(98)00157-9.
9
Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.促肾上腺皮质激素释放因子(CRF)受体-配体相互作用中N端结构域的影响。
Biochemistry. 2005 Feb 8;44(5):1614-23. doi: 10.1021/bi049022e.
10
A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.单个氨基酸作为促肾上腺皮质激素释放因子受体与结合蛋白之间的亲和力开关:对激动剂和拮抗剂设计的启示。
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11142-7. doi: 10.1073/pnas.211424998.

引用本文的文献

1
Anxiolytic-like effects of antisauvagine-30 in mice are not mediated by CRF2 receptors.抗 Sauvagine-30 在小鼠体内产生的抗焦虑样作用不通过 CRF2 受体介导。
PLoS One. 2013 Aug 28;8(8):e63942. doi: 10.1371/journal.pone.0063942. eCollection 2013.
2
Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.中枢神经系统中促肾上腺皮质激素释放因子(CRF)受体信号传导:新的分子靶点。
CNS Neurol Disord Drug Targets. 2006 Aug;5(4):453-79. doi: 10.2174/187152706777950684.
3
Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
可他吉宁是促肾上腺皮质激素释放因子受体1亚型的特异性激动剂,在小鼠模型中具有致焦虑和抗抑郁作用。
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9468-73. doi: 10.1073/pnas.0403159101. Epub 2004 Jun 10.